Published in Blood Weekly, June 6th, 2002
Dr. Yoshimune Sakaki and colleagues working at Kagoshima University in Kagoshima performed a study to investigate the "significance of human T-cell lymphotropic virus type I (HTLV-I) Tax protein-induced resistance to anticancer drugs and the relationship between Tax and multidrug resistance proteins."
The effects of Tax were mediated by other proteins linked to drug resistance, but not the proteins widely assumed to be upregulated by Tax, Sakaki and coauthors found.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.